Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsisAlan S. Cross, Apurba K. Bhattacharjee, Steven M. Opal et al.|Vaccine|2003Cited by 32
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjectsAlan S. Cross, Apurba K. Bhattacharjee, Steven M. Opal et al.|Vaccine|2003Cited by 31